Data supporting the structural and functional characterization of Thrombin-Activatable Fibrinolysis Inhibitor in breast cancer

about

Data supporting the structural and functional characterization of Thrombin-Activatable Fibrinolysis Inhibitor in breast cancer

Item

http://www.wikidata.org/entity/Q35887881

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Data supporting the structural ...... sis Inhibitor in breast cancer

@ast

Data supporting the structural ...... sis Inhibitor in breast cancer

@en

type

Item

label

Data supporting the structural ...... sis Inhibitor in breast cancer

@ast

Data supporting the structural ...... sis Inhibitor in breast cancer

@en

prefLabel

Data supporting the structural ...... sis Inhibitor in breast cancer

@ast

Data supporting the structural ...... sis Inhibitor in breast cancer

@en

P1476

Data supporting the structural ...... sis Inhibitor in breast cancer

@en

P2093

Eman A Toraih

http://www.w3.org/2001/XMLSchema#string

Manal S Fawzy

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation

A method and server for predicting damaging missense mutations

Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma

Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).

Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge

Protter: interactive protein feature visualization and integration with experimental proteomic data.

Fibrinolysis and the control of blood coagulation.

Thrombin and fibrinolysis.

Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study.

P304

981-989

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DIB.2015.10.043

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manal S. Fawzy

Eman A Toraih

P577

2015-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284136686

http://www.w3.org/2001/XMLSchema#string

P698

26740968

http://www.w3.org/2001/XMLSchema#string

P932

4675892

http://www.w3.org/2001/XMLSchema#string